Adrienne Graves

Adrienne Graves

Director/Board Member at OCULAR THERAPEUTIX, INC.

Net worth: 942 296 $ as of 2026-10-30

71 year
Health Technology
Commercial Services
Miscellaneous

Profile

Dr. Adrienne L.
Graves
is an Independent Director at Opus Genetics, Inc., an Independent Director at Harrow, Inc., an Independent Director at Ocular Therapeutix, Inc., an Independent Director at Qlaris Bio, Inc., a Chairman at Retinal Degeneration Fund, a Member at American Glaucoma Society, a Member at The Association for Research in Vision & Ophthalmology and a Member at Women in Ophthalmology, Inc. She is on the Board of Directors at Opus Genetics, Inc., Harrow, Inc., Osanni Bio, Inc., G-Metrics GmbH, Ocular Therapeutix, Inc., JelliSee Ophthalmics, Inc., NVasc, Inc., The Foundation Fighting Blindness, Inc., Qlaris Bio, Inc., American Academy of Ophthalmology, Inc., The American Society of Cataract & Refractive Surgery, Glaucoma Research Foundation, American Academy of Ophthalmology Foundation, American Society of Cataract & Refractive Surgery Foundation, Himalayan Cataract Project, KeepYourSight Foundation, Pan-American Ophthalmological Foundation and Retina Global.
Dr. Graves was previously employed as a Chairman by IVERIC bio, Inc., a Non-Executive Director by Oxurion NV, an Independent Director by Greenbrook TMS, Inc., an Independent Director by Surface Ophthalmics, Inc., an Independent Director by Nicox SA, an Independent Director by Akorn, Inc., an Independent Director by Aerpio Therapeutics, Inc., an Independent Director by Encore Vision, Inc., an Independent Director by Trukera Medical, a Vice President-Clinical Affairs by Santen, Inc., a Director-International Ophthalmology by Alcon Laboratories, Inc., and a Co-Founder by Ophthalmic Women Leaders.
She also served on the board at Opus Genetics, Inc. /OLD/, TherOptix, Inc., Nicox Ophthalmics, Inc., Envisia Therapeutics, Inc., Aerpio Pharmaceuticals, Inc. and Ophthalmic World Leaders.
She received her undergraduate degree from Brown University and a doctorate degree from the University of Michigan.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-19 127,514 ( 0.15% ) 467 976 $ 2026-10-30
2026-06-09 64,000 ( 0.03% ) 446 080 $ 2026-10-30
2026-06-17 1,000 ( 0% ) 28 240 $ 2026-10-30

Adrienne Graves active positions

CompaniesPositionStart
OCULAR THERAPEUTIX, INC. Director/Board Member 2023-07-09
HARROW, INC. Director/Board Member 2024-01-25
OPUS GENETICS, INC. Director/Board Member 2024-10-21
Founder 2006-12-31
Chairman 2022-07-20
Director/Board Member 2008-12-31
American Academy of Ophthalmology Foundation
Director/Board Member 2006-12-31
Director/Board Member 2010-05-19
Director/Board Member -
░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░

Former positions of Adrienne Graves

CompaniesPositionEnd
░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Adrienne Graves's experience

Education of Adrienne Graves

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

40

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies40

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Pan-American Ophthalmological Foundation

Commercial Services

Commercial Services

Miscellaneous

Commercial Services

Ophthalmic Women Leaders

Health Technology

Health Technology

Commercial Services

American Academy of Ophthalmology Foundation

Commercial Services

Electronic Technology

Health Services

Miscellaneous

Commercial Services

Health Technology

Health Technology

Health Services

Health Technology

Miscellaneous

Health Technology

Electronic Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Adrienne Graves